{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:26:55Z","timestamp":1777436815122,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2014544"],"award-info":[{"award-number":["APP2014544"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GI\/2"],"award-info":[{"award-number":["GI\/2"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117463","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:55:52Z","timestamp":1761432952000},"page":"117463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Functional and structural interactions of novel acrylamide-based compounds with the \u03b17 nicotinic acetylcholine receptor"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-7194","authenticated-orcid":false,"given":"Han-Shen","family":"Tae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo O.","family":"Ortells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna M.","family":"Targowska-Duda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria N.","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo R.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2025.117463_b0005","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1152\/jn.01030.2012","article-title":"\u03b17-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability","volume":"110","author":"Pidoplichko","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2025.117463_b0010","doi-asserted-by":"crossref","unstructured":"Z.Q. Xu, W.J. Zhang, D.F. Su, G.Q. Zhang, C.Y. Miao, Cellular responses and functions of \u03b17 nicotinic acetylcholine receptor activation in the brain: a narrative review, Ann. Transl. Med. 9 (6) (2021) 509, 10.21037\/atm-21-273.","DOI":"10.21037\/atm-21-273"},{"issue":"12","key":"10.1016\/j.bcp.2025.117463_b0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117463_b0020","doi-asserted-by":"crossref","unstructured":"M.M. Marcus, C. Bjorkholm, A. Malmerfelt, A. Moller, N. Pahlsson, A. Konradsson-Geuken, K. Feltmann, K. Jardemark, B. Schilstrom, T.H. Svensson, Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study, Eur. Neuropsychopharmacol. 26 (9) (2016) 1401-1411, 10.1016\/j.euroneuro.2016.07.004.","DOI":"10.1016\/j.euroneuro.2016.07.004"},{"key":"10.1016\/j.bcp.2025.117463_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pnpbp.2018.05.018","article-title":"Effects of alpha-7 nicotinic allosteric modulator PNU 120596 on depressive-like behavior after lipopolysaccharide administration in mice","volume":"86","author":"Alzarea","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117463_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbr.2019.03.019","article-title":"Alpha-7 nicotinic receptor allosteric modulator PNU120596 prevents lipopolysaccharide-induced anxiety, cognitive deficit and depression-like behaviors in mice","volume":"366","author":"Alzarea","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117463_b0035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0269881118821100","article-title":"3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of \u03b17 nicotinic receptors, produces anxiolytic-like activity in mice","volume":"33","author":"Targowska-Duda","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bcp.2025.117463_b0040","doi-asserted-by":"crossref","unstructured":"H.R. Arias, C. Ghelardini, E. Lucarini, H.S. Tae, A. Yousuf, I. Marcovich, D. Manetti, M.N. Romanelli, A.B. Elgoyhen, D.J. Adams, L. Di Cesare Mannelli, (E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its derivative DM489 decrease neuropathic pain in mice predominantly by \u03b17 nicotinic acetylcholine receptor potentiation, ACS Chem. Neurosci. 11 (21) (2020) 3603-3614, 10.1021\/acschemneuro.0c00476.","DOI":"10.1021\/acschemneuro.0c00476"},{"issue":"12","key":"10.1016\/j.bcp.2025.117463_b0045","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01616412.2021.1949684","article-title":"(E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by \u03b17 nicotinic acetylcholine receptor potentiation","volume":"43","author":"Bagdas","year":"2021","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bcp.2025.117463_b0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.euroneuro.2021.06.006","volume":"52","author":"Targowska-Duda","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2025.117463_b0055","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1021\/bi102001m","article-title":"Novel positive allosteric modulators of the human \u03b17 nicotinic acetylcholine receptor","volume":"50","author":"Arias","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2025.117463_b0060","doi-asserted-by":"crossref","unstructured":"Y. Zhao, S. Liu, Y. Zhou, M. Zhang, H. Chen, H. Eric Xu, D. Sun, L. Liu, C. Tian, Structural basis of human \u03b17 nicotinic acetylcholine receptor activation, Cell Res. 31 (6) (2021) 713-716, 10.1038\/s41422-021-00509-6.","DOI":"10.1038\/s41422-021-00509-6"},{"key":"10.1016\/j.bcp.2025.117463_b0065","doi-asserted-by":"crossref","unstructured":"T.H. Nishiyama, N.; Hayashi, K.; Obata, M.; Taninaka, K.; Yamane, M.; Oda, S.; Abe, T.; Ishikura, M.; Hibino, S.; Choshi, T., One-pot synthesis of fused 2-pyridones from heteroarylacrylic acid via curtius rearrangement & microwave-assisted thermal electrocyclization, Heterocycles. 95 (2017) 251-267,.","DOI":"10.3987\/COM-16-S(S)13"},{"issue":"3","key":"10.1016\/j.bcp.2025.117463_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/molpharm.123.000692","article-title":"Chemical, pharmacological, and structural characterization of novel acrylamide-derived modulators of the GABAA receptor","volume":"104","author":"Arias","year":"2023","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117463_b0075","doi-asserted-by":"crossref","unstructured":"K.J.C. Bowers, D. E.; Xu, H.; Dror, O. D.; Eastwood, M, P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; Moraes, M. A.; Sacerdoti, F. D.; Salmon, J. K.; Shan, Y.; Shaw, D. E., Scalable algorithms for molecular dynamics simulations on commodity clusters., SC '06: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, Tampa, FL, USA. (2006) 43, 10.1109\/SC.2006.54.","DOI":"10.1109\/SC.2006.54"},{"issue":"13","key":"10.1016\/j.bcp.2025.117463_b0080","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: the proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"27","key":"10.1016\/j.bcp.2025.117463_b0085","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward realistic biological membrane simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117463_b0090","doi-asserted-by":"crossref","first-page":"15451","DOI":"10.1038\/s41598-017-15571-7","article-title":"Protein-ligand blind docking using QuickVina-W with inter-process spatio-temporal integration","volume":"7","author":"Hassan","year":"2017","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.bcp.2025.117463_b0095","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2025.117463_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116183","article-title":"Tabernanthalog and ibogainalog inhibit the \u03b17 and \u03b19\u03b110 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel","volume":"223","author":"Tae","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.bcp.2025.117463_b0105","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"14","key":"10.1016\/j.bcp.2025.117463_b0110","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/bioinformatics\/btw215","article-title":"CaFE: a tool for binding affinity prediction using end-point free energy methods","volume":"32","author":"Liu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bcp.2025.117463_b0115","doi-asserted-by":"crossref","unstructured":"W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, J. Mol. Graph. 14 (1) (1996) 33-38, 27-38, 10.1016\/0263-7855(96)00018-5.","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"10.1016\/j.bcp.2025.117463_b0120","doi-asserted-by":"crossref","unstructured":"H.R. Arias, H.S. Tae, L. Micheli, A. Yousuf, D. Manetti, M.N. Romanelli, C. Ghelardini, D.J. Adams, L. Di Cesare Mannelli, The antinociceptive activity of (E)-3-(thiophen-2-yl)- N -(p-tolyl)acrylamide in mice is reduced by (E)-3-(furan-2-yl)- N -methyl- N -(p-tolyl)acrylamide through opposing modulatory mechanisms at the \u03b17 nicotinic acetylcholine receptor, Anesth. Analg. 137 (3) (2023) 691-701, 10.1213\/ANE.0000000000006461.","DOI":"10.1213\/ANE.0000000000006461"},{"key":"10.1016\/j.bcp.2025.117463_b0125","doi-asserted-by":"crossref","unstructured":"R.L. Papke, J.K. Porter Papke, Comparative pharmacology of rat and human \u03b17 nAChR conducted with net charge analysis, Br. J. Pharmacol. 137 (1) (2002) 49-61, 10.1038\/sj.bjp.0704833.","DOI":"10.1038\/sj.bjp.0704833"},{"key":"10.1016\/j.bcp.2025.117463_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106759","article-title":"Potentiation and allosteric agonist activation of \u03b17 nicotinic acetylcholine receptors: binding sites and hypotheses","volume":"191","author":"Sanders","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117463_b0175","doi-asserted-by":"crossref","unstructured":"S.M. Burke, M. Avstrikova, C.M. Noviello, N. Mukhtasimova, J.P. Changeux, G.A. Thakur, S.M. Sine, M. Cecchini, R.E. Hibbs, Structural mechanisms of \u03b17 nicotinic receptor allosteric modulation and activation, Cell. 187 (5) (2024) 1160-1176 e1121, 10.1016\/j.cell.2024.01.032.","DOI":"10.1016\/j.cell.2024.01.032"},{"key":"10.1016\/j.bcp.2025.117463_b0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.toxlet.2022.11.018","article-title":"A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment","volume":"373","author":"Kaiser","year":"2023","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2025.117463_b0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxlet.2024.01.003","article-title":"MS Binding Assays with UNC0642 as reporter ligand for the MB327 binding site of the nicotinic acetylcholine receptor","volume":"392","author":"Nitsche","year":"2024","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2025.117463_b0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuropharm.2018.07.009","article-title":"Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the \u03b17 nicotinic acetylcholine receptor","volume":"139","author":"Smelt","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117463_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109836","article-title":"BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents","volume":"246","author":"O'Connor","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117463_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116387","article-title":"A phase 2, placebo-controlled study to evaluate the efficacy and safety of BNC210, an alpha-7 nicotinic receptor negative allosteric modulator, for acute, as-needed treatment of social anxiety disorder (SAD) - the PREVAIL study","volume":"346","author":"Papapetropoulos","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bcp.2025.117463_b0150","article-title":"Negative and positive allosteric modulators of the \u03b17 nicotinic acetylcholine receptor regulates the ability of adolescent binge alcohol exposure to enhance adult alcohol consumption","volume":"16","author":"Rodd","year":"2022","journal-title":"Front. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117463_b0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpddr.2016.02.001","article-title":"The Ascaris suum nicotinic receptor, ACR-16, as a drug target: four novel negative allosteric modulators from virtual screening","volume":"6","author":"Zheng","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"4","key":"10.1016\/j.bcp.2025.117463_b0130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/mol.112.080317","article-title":"Intrinsically low open probability of \u03b17 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures","volume":"82","author":"Williams","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117463_b0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jnc.13049","article-title":"Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca2+ release from the endoplasmic reticulum","volume":"133","author":"Guerra-Alvarez","year":"2015","journal-title":"J. Neurochem."},{"issue":"24","key":"10.1016\/j.bcp.2025.117463_b0160","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1111\/bph.15948","article-title":"Modulation of the mammalian GABAA receptor by type I and type II positive allosteric modulators of the \u03b17 nicotinic acetylcholine receptor","volume":"179","author":"Arias","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117463_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040698","article-title":"Mutational analysis of anesthetic binding sites and their effects on GABAA receptor activation and modulation by positive allosteric modulators of the \u03b17 nicotinic receptor","volume":"13","author":"Pierce","year":"2023","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.bcp.2025.117463_b0190","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03b17 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2025.117463_b0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/mol.117.110551","article-title":"Diversity of nicotinic acetylcholine receptor positive allosteric modulators revealed by mutagenesis and a revised structural model","volume":"93","author":"Newcombe","year":"2018","journal-title":"Mol. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:00:03Z","timestamp":1777377603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"alternative-id":["S0006295225007282"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117463","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional and structural interactions of novel acrylamide-based compounds with the \u03b17 nicotinic acetylcholine receptor","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117463"}}